Actinic Keratoses
International guidelines recommend PDT as first-line treatment for actinic keratoses
Published in Healthcare Mergers, Acquisitions and Ventures Week, February 24th, 2007
PDT, a combination of light therapy and photosensitive topical solution, is often used to treat AKs, a common skin condition that, if left untreated, can lead to squamous cell carcinoma (skin cancer). According to the recommendations, PDT should be considered as a first-line therapy for treating the precancerous lesions. The Levulan PDT system (Levulan Kerastick together with the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- Abdominal Aortic Aneurysms
Stanford researchers launch study on effects of exercise on abdominal aneurysms - Accreditation
Healthways receives NCQA full accreditation for depression and oncology - Accreditation
Humana Military Healthcare Services receives URAC HIPAA Privacy Accreditation - Addiction Medicine
Ortho-Clinical Diagnostics offers complete drugs-of-abuse panel, adds five assays - Addiction Medicine
Ovation, National Institute on Drug Abuse study vigabatrin in cocaine addiction - Adipose Tissue
Research in the area of adipose tissue reported from Wyeth Pharmaceuticals - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
